134 related articles for article (PubMed ID: 7540498)
1. Separation of lipoproteins, albumin and gamma-globulin by single-step ultracentrifugation of human serum. Application. I: Binding of hematoporphyrin to human serum and to albumin.
Kongshaug M; Moan J
Int J Biochem Cell Biol; 1995 Apr; 27(4):371-84. PubMed ID: 7540498
[TBL] [Abstract][Full Text] [Related]
2. Hematoporphyrin diethers--V. Plasma protein binding and photosensitizing efficiency.
Kongshaug M; Rimington C; Evensen JF; Peng Q; Moan J
Int J Biochem; 1990; 22(10):1127-31. PubMed ID: 2149708
[TBL] [Abstract][Full Text] [Related]
3. Characterization of spin-labelled fatty acids and hematoporphyrin binding sites interactions in serum albumin.
Gantchev TG; Shopova MB
Biochim Biophys Acta; 1990 Mar; 1037(3):422-34. PubMed ID: 2155659
[TBL] [Abstract][Full Text] [Related]
4. Binding of etiopurpurin and tin-coordinated etiopurpurin to human plasma proteins. Delivery in cremophore EL and dimethyl sulfoxide (paper II).
Kongshaug M; Cheng LS; Moan J; Morgan AR
Int J Biochem Cell Biol; 1995 Jan; 27(1):71-87. PubMed ID: 7757884
[TBL] [Abstract][Full Text] [Related]
5. Plasma protein binding of the reversible type A MAO inhibitor cimoxatone (MD 780515).
Rovei V; Chanoine F; Strolin Benedetti M; Zini R; Tillement JP
Biochem Pharmacol; 1983 Aug; 32(15):2303-8. PubMed ID: 6192825
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo.
Jori G; Beltramini M; Reddi E; Salvato B; Pagnan A; Ziron L; Tomio L; Tsanov T
Cancer Lett; 1984 Oct; 24(3):291-7. PubMed ID: 6498807
[TBL] [Abstract][Full Text] [Related]
7. Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition.
Pietzsch J; Subat S; Nitzsche S; Leonhardt W; Schentke KU; Hanefeld M
Biochim Biophys Acta; 1995 Jan; 1254(1):77-88. PubMed ID: 7811751
[TBL] [Abstract][Full Text] [Related]
8. Steady-state and time-resolved spectroscopic studies on the hematoporphyrin-lipoprotein complex.
Beltramini M; Firey PA; Ricchelli F; Rodgers MA; Jori G
Biochemistry; 1987 Oct; 26(21):6852-8. PubMed ID: 3427046
[TBL] [Abstract][Full Text] [Related]
9. Binding of erythromycin base to human plasma proteins.
Prandota J; Tillement JP; d'Athis P; Campos H; Barre J
J Int Med Res; 1980; 8 Suppl 2():1-8. PubMed ID: 7429002
[TBL] [Abstract][Full Text] [Related]
10. Using capillary electrophoresis/frontal analysis to screen drugs interacting with human serum proteins.
McDonnell PA; Caldwell GW; Masucci JA
Electrophoresis; 1998 Mar; 19(3):448-54. PubMed ID: 9551800
[TBL] [Abstract][Full Text] [Related]
11. Blood distribution of levocetirizine, a new non-sedating histamine H1-receptor antagonist, in humans.
Bree F; Thiault L; Gautiers G; Benedetti MS; Baltes E; Rihoux JP; Tillement JP
Fundam Clin Pharmacol; 2002 Dec; 16(6):471-8. PubMed ID: 12685505
[TBL] [Abstract][Full Text] [Related]
12. The binding of dihematoporphyrin ether (photofrin II) to human serum albumin.
Moan J; Rimington C; Western A
Clin Chim Acta; 1985 Feb; 145(3):227-36. PubMed ID: 3157506
[TBL] [Abstract][Full Text] [Related]
13. Binding of human serum proteins to titanium dioxide particles in vitro.
Zaqout MS; Sumizawa T; Igisu H; Higashi T; Myojo T
J Occup Health; 2011; 53(2):75-83. PubMed ID: 21245653
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamics of the binding of hematoporphyrin ester, a hematoporphyrin derivative-like photosensitizer, and its components to human serum albumin, human high-density lipoprotein and human low-density lipoprotein.
Rosenberger V; Margalit R
Photochem Photobiol; 1993 Nov; 58(5):627-30. PubMed ID: 8284316
[TBL] [Abstract][Full Text] [Related]
15. Interaction of human serum albumin with hematoporphyrin and its Zn(2)+-and Fe(3)+-derivatives.
Reddi E; Ricchelli F; Jori G
Int J Pept Protein Res; 1981 Oct; 18(4):402-8. PubMed ID: 7309386
[TBL] [Abstract][Full Text] [Related]
16. Role of high-, low- and very low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo.
Barel A; Jori G; Perin A; Romandini P; Pagnan A; Biffanti S
Cancer Lett; 1986 Aug; 32(2):145-50. PubMed ID: 3756840
[TBL] [Abstract][Full Text] [Related]
17. Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin. Optical and NMR spectroscopy characterization.
Fanali G; Fesce R; Agrati C; Ascenzi P; Fasano M
FEBS J; 2005 Sep; 272(18):4672-83. PubMed ID: 16156788
[TBL] [Abstract][Full Text] [Related]
18. The binding of aprindine to serum proteins with statistical considerations concerning the analysis of binding data.
Andreasen F; Husted S; Jakobsen P; Jensen EB
Acta Pharmacol Toxicol (Copenh); 1980 Feb; 46(2):105-12. PubMed ID: 7361564
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective binding of chiral anti-diabetic drug nateglinide to plasma proteins.
Maddi S; Scriba G; Yamsani MR
Drug Metabol Drug Interact; 2011; 26(2):81-6. PubMed ID: 21732706
[TBL] [Abstract][Full Text] [Related]
20. Binding of chlorpromazine and imipramine to red cells, albumin, lipoproteins and other blood components.
Bickel MH
J Pharm Pharmacol; 1975 Oct; 27(10):733-8. PubMed ID: 241785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
